Home    Corporate    Technology    News    FAQ    Job Opportunities    Contact
 
 
 
 
 
Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy.
 
 
Intralytix, Inc. is a biotechnology company focused on the production and marketing of products using bacteriophages to control bacterial pathogens in environmental, food processing, and medical settings.

Bacteriophage: viruses that are parasites of bacteria. Bacteria-eater (from the Greek phago meaning “to eat” or “to develop at the expense of”)

 
 
  In the News

Intralytix Wins Army Grant for Salmonella and Shigella Technology
Intralytix awarded patent by USPTO for Bacteriophage treatment of colonization by pathogen bacteria, including MRSA
Intralytix wins Phase III Army grant for E. Coli technology
Intralytix has received a registration from the Environmental Protection Agency (“EPA”) for LMP-102™ as an antimicrobial for use against Listeria monocytogenes.
NPR Talk of the Nation - Science Friday story featuring Intralytix Vice President, Alexander Sulakvelidze
Intralytix and its LMP-102™ phage cocktail have been chosen to receive a 2006 Best of What’s New Award from Popular Science
FDA Approves Intralytix's Food Safety Product, LMP-102
CNN's Dr. Sanjay Gupta on the FDA approval of LMP-102
CBS News Report - Spray For Bacteria Free Meat

 

 

 
 

 

 

 

   Food Safety    Environmental Sanitation    Veterinary Applications    Human Therapeutics


Copyright 2008 Intralytix, Inc. All rights reserved